Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06745297
PHASE1

A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated

Sponsor: Boehringer Ingelheim

View on ClinicalTrials.gov

Summary

The trial aims to study the safety, tolerability, and pharmacokinetics of single and multiple rising doses of BI 3776528.

Official title: A Two-part, Randomised, Single-blind, Placebo-controlled, Single and Multiple Rising Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of BI 3776528, Administered to Healthy Male Participants

Key Details

Gender

MALE

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

142

Start Date

2025-01-23

Completion Date

2026-08-25

Last Updated

2025-11-21

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

BI 3776528

BI 3776528

DRUG

Placebo matching BI 3776528

Placebo matching BI 3776528

DRUG

short-acting benzodiazepine

short-acting benzodiazepine

Locations (1)

Charité Research Organisation GmbH

Berlin, Germany